← Back to headlines
Wells Fargo Cuts Price Target on Soleno Therapeutics (SLNO)
Wells Fargo has reduced its price target for Soleno Therapeutics (SLNO) from $114 to $110, citing specific reasons for the adjustment.
1 Mar, 09:27 — 1 Mar, 09:27
ℹOnly 1 source covers this story
